Hirano bodies are cytoplasmic inclusions described in association with the cellular pathology of aging, and a variety of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis. Since previous studies of Hirano bodies have been performed on preserved clinical brain samples, there is no direct information on the effects of Hirano bodies on cell physiology, aging, or neurodegenerative disease. A model for formation of Hirano bodies in cultured cells has recently been described. The model Hirano bodies are indistinguishable from Hirano bodies in pathology samples in all criteria described by prior ultrastructural and immunohistochemical studies of Hirano bodies. Since Hirano bodies are a widespread type of cytoplasmic protein inclusion associated with numerous significant diseases, it is important to determine their effects on the physiology of neuronal cells.
The aim of this project is to test the following 3 alternative hypotheses: 1) Hirano bodies promote/ reflect cellular pathology and toxicity; 2) Hirano bodies are adaptive structures that promote survival of neuronal cells under stresses that are known to contribute to neurodegenerative diseases; or 3) Hirano bodies have no effect on survival of neuronal cells under physiological stress. The effect of Hirano bodies on the neurotoxicity of 5 stresses implicated in the pathology of neurodegenerative disease will be determined. These 5 stresses are: 1) oxidative stress that damages protein, lipid, and nucleic acid; 2) glutamate excitotoxicity that initiates prolonged elevation of intracellular calcium; 3) ischemia (ATP depletion) most commonly associated with stroke or hypoxia; 4) Ab peptide, the leading candidate for initiation of the pathology of Alzheimer's disease; and 5) the intracellular cytoplasmic domain of the amyloid precursor protein (AICD) that can initiate programmed cell death. The results will provide a direct test of the hypothesis that Hirano bodies affect the survival of neuronal cells challenged with physiological stress by promoting either the death or the survival of neurons in disease. Elucidation of the potential roles of Hirano bodies in disease is prerequisite to possible development of animal models, interventions, or therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS046451-02
Application #
7089055
Study Section
Neurodegeneration and Biology of Glia Study Section (NDBG)
Program Officer
Sutherland, Margaret L
Project Start
2005-07-01
Project End
2010-05-14
Budget Start
2006-07-01
Budget End
2010-05-14
Support Year
2
Fiscal Year
2006
Total Cost
$166,201
Indirect Cost
Name
University of Georgia
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Clark, Jason K; Furgerson, Matthew; Crystal, Jonathon D et al. (2015) Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice. Neurobiol Learn Mem 125:152-162
Furgerson, Matthew; Fechheimer, Marcus; Furukawa, Ruth (2012) Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain. PLoS One 7:e44996
Klionsky, Daniel J (see original citation for additional authors) (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:445-544
Ha, Sangdeuk; Furukawa, Ruth; Stramiello, Michael et al. (2011) Transgenic mouse model for the formation of Hirano bodies. BMC Neurosci 12:97
Ha, Sangdeuk; Furukawa, Ruth; Fechheimer, Marcus (2011) Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis. Neurobiol Aging 32:2287-98
Kim, Dong-Hwan; Davis, Richard C; Furukawa, Ruth et al. (2009) Autophagy contributes to degradation of Hirano bodies. Autophagy 5:44-51